Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults (Q47225463)

12 January 2018

title

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults (English)

1 reference

12 January 2018

1

Pierre Van Damme

1 reference

12 January 2018

Froukje Oosterhuis-Kafeja

2

1 reference

12 January 2018

Marie Van der Wielen

3

1 reference

12 January 2018

Yotam Almagor

4

1 reference

12 January 2018

Ofer Sharon

5

1 reference

12 January 2018

Yotam Levin

6

1 reference

12 January 2018

language of work or name

English

0 references

publication date

18 November 2008

1 reference

12 January 2018

published in

Vaccine

1 reference

12 January 2018

volume

27

1 reference

12 January 2018

page(s)

454-459

1 reference

12 January 2018

issue

3

1 reference

12 January 2018

Influenza-associated hospitalizations in the United States

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Effectiveness of influenza vaccine in the community-dwelling elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Vaccines for seasonal and pandemic influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Dose sparing with intradermal injection of influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Serum antibody responses after intradermal vaccination against influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Antibody responses after dose-sparing intradermal influenza vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Intradermal influenza vaccination--can less be more?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Efficacy and side effects of intradermal hepatitis B vaccination in CAPD patients: a comparison with the intramuscular vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Influence of needle gauge in Mantoux skin testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Intradermal injections: traditional bevel up versus bevel down

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Skin thickness of Korean adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

EDWARD JENNER: THE HISTORY OF A MEDICAL MYTH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

THE ANTIBODY RESPONSE OF HUMAN SUBJECTS VACCINATED WITH THE VIRUS OF HUMAN INFLUENZA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Intradermal hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Rabies intradermal post-exposure vaccination of humans using reconstituted and stored vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

Smallpox vaccination techniques; from knives and forks to needles and pins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.077

10.1016/J.VACCINE.2008.10.077

7 January 2021

Identifiers

DOI

1 reference

12 January 2018

PubMed ID

19022318

1 reference

12 January 2018